Axon Enterprise, INC Form 4 insider transactions

Axon Enterprise, Inc. President Joshua Isner reported the disposition of 1,585 shares of common stock through tax withholding and a pre-arranged 10b5-1 trading plan.

Axon Enterprise's Chief Accounting Officer, Jennifer H. Mak, sold 75 shares of common stock for $771.81 per share on June 13, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise's Chief Accounting Officer, Jennifer H. Mak, disposed of 2,150 shares of common stock on June 2, 2025, primarily to cover tax obligations arising from the vesting of restricted stock units.

Axon Enterprise, Inc. Director Michael Garnreiter reported the sale of 6,000 shares of common stock and a charitable gift of 1,000 shares, reducing his beneficial ownership to 17,740 shares.

Axon Enterprise, Inc.'s Chief Operating Officer and Chief Financial Officer, Brittany Bagley, reported a disposition of 15,876 shares of common stock to cover tax liabilities arising from the vesting of restricted stock units.

Axon Enterprise, Inc. President Joshua Isner disposed of 28,489 shares of common stock on June 2, 2025, valued at $758.57 per share, to satisfy tax obligations related to the vesting of restricted stock units.

Jeffrey C. Kunins, Chief Product Officer and Chief Technology Officer of Axon Enterprise, Inc., disposed of 7,928 shares of common stock to satisfy tax liabilities related to the vesting of restricted stock units.

Axon Enterprise's Chief Revenue Officer, Cameron Brooks, sold 3,000 shares of common stock for approximately $2.22 million under a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise, Inc. Director Matthew R. McBrady was granted 446 time-vested restricted stock units on May 29, 2025, increasing his beneficial ownership to 3,938 shares.

Axon Enterprise, Inc. Director Jeri Williams was granted 446 time-vested restricted stock units, increasing her beneficial ownership to 1,416 shares.

Axon Enterprise, Inc. Director Adriane M. Brown was granted 446 time-vested restricted stock units on May 29, 2025, increasing her beneficial ownership to 7,826 shares.

Axon Enterprise, Inc. Director Michael Garnreiter was granted 481 time-vested restricted stock units, increasing his direct beneficial ownership to 24,740 shares.

Axon Enterprise, Inc. Director Caitlin Elizabeth Kalinowski was granted 446 time-vested restricted stock units on May 29, 2025, increasing her beneficial ownership to 5,275 shares.

Axon Enterprise, Inc. Director Graham Smith was granted 446 time-vested restricted stock units, increasing his direct beneficial ownership to 3,018 shares.

Axon Enterprise, Inc. Director Julie A. Cullivan was granted 446 shares of common stock as time-vested restricted stock units, a standard compensation practice.

Axon Enterprise, Inc. Director Erika Nardini was granted 446 time-vested restricted stock units (RSUs) on May 29, 2025, as part of her compensation.

Axon Enterprise, Inc. Director Hadi Partovi reported the acquisition of 446 common shares through a restricted stock unit grant, bringing his total beneficial ownership to 236,580 shares, alongside a disclosure regarding previous transfers to a former spouse.

Cameron Brooks, Axon Enterprise's Chief Revenue Officer, files an amendment to correct the number of shares withheld for tax purposes and the number of shares beneficially owned following a recent transaction.

Axon Enterprise's President, Joshua Isner, executed multiple sales of common stock on May 21, 2025, at prices ranging from $731.422 to $748.1125.

Director Caitlin Elizabeth Kalinowski reported selling 1,300 shares of Axon Enterprise, Inc. common stock on May 19, 2025.

Cameron Brooks, Chief Revenue Officer of Axon Enterprise, sold shares to cover tax liabilities arising from the vesting of restricted stock units.

Brittany Bagley, COO & CFO of Axon Enterprise, sold 3,400 shares of common stock on May 13, 2025.

Director Caitlin Elizabeth Kalinowski of Axon Enterprise, Inc. sold 800 shares of common stock on May 13, 2025, at a price of $713.25 per share.

Director Matthew McBrady of Axon Enterprise, Inc. sold 400 shares of common stock at a weighted average price of $718.4043 on May 14, 2025.

Axon Enterprise's President, Joshua Isner, executed multiple sales of common stock on May 12, 2025, at prices ranging from $667.21 to $701.67.

Director Julie A. Cullivan sold 657 shares of Axon Enterprise, Inc. common stock at $700 per share on May 12, 2025, under a pre-arranged 10b5-1 trading plan.

Director Jeri Williams sold 657 shares of Axon Enterprise, Inc. common stock on May 12, 2025, under a pre-arranged 10b5-1 trading plan.

Axon Enterprise's CEO, Patrick W. Smith, sold shares of common stock on April 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Brittany Bagley, COO & CFO of Axon Enterprise, disposed of 1,250 shares of common stock on March 26, 2025, to cover tax liabilities from vesting restricted stock units.

Brittany Bagley, COO & CFO of Axon Enterprise, acquired 61,120 shares of common stock on March 24, 2025, related to performance-based restricted stock units.